Showing results (981-990 of 1,436) with videos related to

Sort By:
Pageof 144
The British Journal of Nutrition|January 8, 2021
No effect of salmon fish protein on 2-h glucose in adults with increased risk of type 2 diabetes: a randomised controlled trialK S Hustad, I Ottestad, M Hjorth, et al.
Ugeskrift for Laeger|April 12, 2017
[Care and treatment can be planned in advance with advance care planning]Marianne Hjorth Skorstengaard, Mogens Grønvold, Anders Bonde Jensen, et al.
The Lancet. Oncology|September 25, 2010
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trialPeter Gimsing, Kristina Carlson, Ingemar Turesson, et al.
Gynecologic Oncology|February 6, 2022
Vaginal melanoma in Denmark from 1980 to 2018: A population-based study based on genetic profile and survivalNatacha Würtz Yazdanfard, Lauge Hjorth Mikkelsen, Nille Behrendt, et al.
American Journal of Epidemiology|May 21, 2021
Maternal Medication Use and Childhood Cancer in Offspring-Systematic Review and Considerations for ResearchersSarah Hjorth, Caroline H Hemmingsen, Justine Bénévent, et al.
Ugeskrift for Laeger|March 1, 2003
[Treatment with antidepressants in geriatric departments. Occurrence and record keeping]Jens-Ulrik Rosholm, Hanne Hollaender Mortensen, Birthe Hjorth Svensson, et al.
Journal of Medicinal Chemistry|February 17, 1995
(R)-11-hydroxy- and (R)-11-hydroxy-10-methylaporphine: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactionsM H Hedberg, A M Johansson, G Nordvall, et al.
BMC Geriatrics|November 16, 2024
Association of frailty with functional difficulty in older Ghanaians: stability between women and men in two samples with different income levelsNestor Asiamah, Emelia Danquah, Edgar Ramos Vieira, et al.
Neuroinformatics|March 3, 2010
Run-time interoperability between neuronal network simulators based on the MUSIC frameworkMikael Djurfeldt, Johannes Hjorth, Jochen M Eppler, et al.
Molecular Cancer Therapeutics|March 13, 2015
The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responsesLisa Christiansson, Stina Söderlund, Sara Mangsbo, et al.
Pageof 144